Martin P Rabe

Martin P Rabe has a vast and extensive work experience in the pharmaceutical industry. Martin P has held various leadership positions in renowned companies. Starting in 1996, they worked as a Manager at Merck until 2002. Martin P then joined Pfizer, Inc. as the Director of WW Regulatory Strategy from 2002 to 2009.

In 2009, Rabe moved to Eisai US, where they served in progressively advancing roles. Martin P began as a Director of Regulatory Affairs and later became the Senior Director of Global Regulatory Affairs, Head of Neuroscience from 2012 to 2014. Subsequently, they were promoted to the position of Executive Director, Global Regulatory Affairs, Head of Neuroscience until 2016. From 2016 to 2021, they held the position of Vice President, Head of Regulatory Strategy and Commercial Regulatory Affairs, Neurology Business Group.

In 2021, Rabe transitioned to Kira Pharmaceuticals, where they worked as a Senior Vice President until 2023. Currently, they hold the position of Executive Vice President and Head of Regulatory Affairs and Quality Assurance at NeuroTrauma Sciences, LLC, starting from April 2023.

Throughout their career, Martin P Rabe has consistently demonstrated expertise in regulatory affairs and quality assurance, making significant contributions to the pharmaceutical industry.

Martin P Rabe obtained a Bachelor of Science degree in Analytical Chemistry from Concordia University, which they attended from 1991 to 1993. Later, they pursued further education at Université Laval where they earned a Bachelor of Science (BSc) degree in Physiology, General, completing their studies from 1996 to 1998.